Johnson & Johnson is the latest drug company to announce it will supply a potential COVID-19 vaccine to the U.S. in exchange for $1 billion as another vaccine maker, Moderna, comes under fire for pricing its potential drug too high.

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en